SENSEX    72408.07       -1058.32    |    NIFTY    21943       -359.50 FAQ    |    Feedback
EQUITIES
DERIVATIVES
IPO
Gainers & Losers Value & Volume Toppers 52 Weeks High/Low Advances & Declines
New High-Low
Pre-Session Mid-Session End-Session Other Markets Market Beat Stock Alert
Hot Pursuit Foreign Markets Economy News Corporate News Corporate Results
Detailed Quotes Board of Directors Balance Sheet Profit & Loss Quarterly Results Historical Price
Financial Ratios Company Background Technical Chart
Announcements Book Closure Board Meetings Bonus Issues Rights Issues
De-Listed Shares Name Change Split of Face Value Market Turnover
FII Investments MF Investments ADR Prices World Indices
Forthcoming IPOs
Open IPOs
Closed IPOs
New Listing
Basis Of Allotment Draft Prospectus New Issue Monitor
Get Quotes
Gainers
Losers
Value Toppers Advances & Declines Ticker Spot
Ticker Futures Closing Price Technical Chart Commodity News MCX Currency Futures
Get Quotes NIFTY Futures Top Traded Value Top Quantity Most Active Contracts
FII Statistics Daily Settlement Price List of Underlyings Put Call Ratio Derivative Summary
All Index Futures Top Gainers Top Losers Most Active Put Most Active Call
Highest in OI Lowest in OI Increase in OI Decrease in OI
Mid - Session Commentary
Market behaviours during the course of the trading session for last one week.
Nifty hovers above 22,400; VIX suprts over 8%
25-Apr-24   12:33 Hrs IST

The key equity benchmarks hovered near the flat line in early afternoon trade. The Nifty traded above the 22,400 level. Pharma stocks gained for second consecutive trading session.

At 12:30 IST, the barometer index, the S&P BSE Sensex, was down 5.50 points or 0.01% to 73,847.44. The Nifty 50 index added 2.25 points or 0.01% to 22,404.65.

In the broader market, the S&P BSE Mid-Cap index rose 0.19% and the S&P BSE Small-Cap index added 0.38%.

The market breadth was strong. On the BSE, 1,985 shares rose and 1,669 shares fell. A total of 158 shares were unchanged.

Politics:

The second phase of voting will be held on April 26 in 89 constituencies spread across 13 states and Union territories. The BJP is looking to consolidate its grip on power as it aims for a historic third term while a band of opposition parties, including the Congress, has formed a united front called Indian National Developmental Inclusive Alliance (INDIA) bloc to deny PM Modi another victory. The elections will occur in 7 phases, from 19 April to 1 June. The Lok Sabha elections 2024 results will declared on 4 June.

Derivatives:

The NSE's India VIX, a gauge of the market's expectation of volatility over the near term, surged 8.63% to 11.16. Volatility zoomed as traders roll over positions in the F&O segment from the near month April series to May series. The April 2024 F&O contracts will expire today, 25 April 2024.

The Nifty 25 April 2024 futures were trading at 22,464, at a premium of 10.35 points as compared with the spot at 22,453.65.

The Nifty option chain for the 25 April 2024 expiry showed maximum Call OI of 308 lakh contracts at the 22,500 strike price. Maximum Put OI of 212.2 lakh contracts were seen at 22,400 strike price.

Buzzing Index:

The Nifty Pharma index rose 0.66% to 18,709.05. The index rallied 1.33% in two consecutive trading sessions.

Natco Pharma (up 2.8%), J B Chemicals & Pharmaceuticals (up 2.37%), Glenmark Pharmaceuticals (up 1.61%), Sun Pharmaceuticals Industries (up 1.22%) and Dr Reddys Laboratories (up 0.99%), Lupin (up 0.92%), Alkem Laboratories (up 0.78%), Divis Laboratories (up 0.71%), Aurobindo Pharma (up 0.61%) and Biocon (up 0.1%) advanced.

On the other hand, Granules India (down 0.92%), Ipca Laboratories (down 0.83%) and Abbott India (down 0.79%) edged lower.

Stocks in Spotlight:

Syngene International declined 0.61%. The company has reported 5.5% rise in net profit to Rs 188.6 crore despite a 7.8% fall in revenue to Rs 916.9 crore in Q4 FY24 over Q4 FY23.

Indian Hotels Company (IHCL) slipped 4.64%. The firm reported 27.26% jump in consolidated net profit to Rs 417.76 crore in the quarter ended 31 March 2024 as compared with Rs 328.27 crore in the quarter ended 31 March 2023. Revenue from operations increased 17.22% YoY to Rs 1,905.34 crore in Q4 FY24 as compared with Rs 1,625.43 crore in Q4 FY23.

Oracle Financial Services Software shed 1.61%. The company reported 15.86% jump in consolidated net profit to Rs 560.12 crore in Q4 FY24 as compared with Rs 479.30 crore in Q4 FY23. Revenue for the quarter was Rs 1,642 crore, up 12% YoY.

Powered by Capital Market - Live News

MARKETS
TODAY'S MARKET SECTOR
BSE NSE
Currencies
Currency EUR GBP INR USD
Europe (EUR) 1.00 0.86 89.85 1.08
United Kingdom (GBP) 1.16 1.00 104.64 1.25
India (INR) 0.01 0.01 1.00 0.01
United States (USD) 0.93 0.80 83.48 1.00
Market News << ALL News
  09-May-2024, (02:45 )  Transwarranty Financ..
  09-May-2024, (02:30 )  Volumes spurt at SKF..
  09-May-2024, (02:00 )  Industrials shares slide
  09-May-2024, (02:00 )  Oil and Gas stocks slide
 Commodities << ALL Commodities
   Attention Investor: Prevent unauthorized transactions in your trading / Demat account : Update your mobile number / e mail ids with your stock broker / deposit." | "No need to issue cheques by investors while subscribing to IPO.Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor’s account." | "KYC is one time exercise while dealing in securities markets- once KYC is done through a SEBI registered intermediary(broker, DP, Mutual Fund etc.) you need not undergo the same process again when you approach another intermediary."
   Disclaimer   |   BSE Disclosure  |  Privacy Policy   |   Investor Protection   |    Inactive Account   |  Vernacular Language: NSE | BSE   |   Feedback   |    PMLA Policy   |   Risk Management Policy   |   Insider Trading   |   Investor Grivenances   |   Investor Complaints   |   Investor Charter   |   Rules And Regulations   |   Broker Norms   |   Terms of Use    Policies & Procedures   |   Risk Disclosure   |   Do & Don’ts   |   Rights & Obligations
  
SEBI Registration No : INZ000267132   |   BSE Clearing No : 333   
   Copyright © 2011 All rights reserved by Jaysukhlal Jagjivan Stock Broking Pvt.Ltd Designed, Developed & Powered By CMOTS INFOTECH (ISO 9001:2015 certified)